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1. Introduction 
The inhibitory action of the hypoglyceamic pent- 
4-enoic acid on mitochondrial metabolism has been 
studied with isolated mitochondria [1,2], as well as 
perfused liver [3] and heart [4]. These studies have 
not, however, given results which are conclusive as to 
the mechanism of action of pent-4-enoic acid, partic- 
ularly as regards its inhibitory effect on t-oxidation of 
other fatty acids. It is generally agreed that pent-4- 
enoic acid is well metabolised by perfused organs at 
perfusate concentrations le s than 1-2 mM, its 
inhibitory properties becoming manifested athigher 
concentrations. With isolated mitochondria it is also 
possible to demonstrate p rsistant oxidation of pent- 
4-enoate present at a low concentration, provided 
that a high concentration f L-camitine has been 
included [5]. Again higher concentrations of pent-4- 
enoate (>300 t~M) inhibits its own oxidation [5]. 
With pent-4-enoylcarnitine, however, it has not been 
possible to demonstrate p rsistant oxidation of this 
fatty acid [2]. The reason for this may involve dif- 
ferent rates of acylation of mitochondrial CoA [6]. 
The inhibition of t-oxidation of other fatty acids 
by pent-4-enoate requires its conversion to pent-4- 
enoyl-CoA [2]. It has been suggested that the 
inhibitory effect of pent-4-enoate is simply due to 
sequestration f cellular CoA and carnitine as 
unmetabolisable esters [7]. It has been shown, 
however, that the inhibition of t-oxidation can be 
dissociated from the inhibition of other mitochon- 
drial reaction requiring CoA, e.g., those involved in 
the oxidation of pyruvate [1,5]. This finding strongly 
suggests that the inhibitory action of pent-4-enoate 
is not purely a matter of CoA sequestration, although 
this may be involved in some aspects of its action 
[6]. The sensitivity of t-oxidation to low concentra- 
tions of pent-4-enoate (and the absence of inhibition 
of pyruvate oxidation under identical conditions) 
suggests that a pent-4-enoate metabolite must have a 
powerfully inhibitory action somewhere in the/3- 
oxidation sequence. The apparently irreversible 
inhibitory effect of penta-2,4-dienoyl-CoA on 
acetoacetyl-CoA thiolase (EC 2.3.1.9) observed with 
the purified enzyme [8] and with soluble mitochon- 
drial extracts [5], is not found following exposure of 
intact mitochondria topent-4-enoate [5]. In intact 
mitochondria the inhibitory effect of pent-4-enoate 
is therefore reversible, and the inhibitory site may be 
located prior to acetoacetyl-CoA thiolase in the 
/J-oxidation system. 
Recently an assay which selectively measures the 
acyl-CoA flux through the acyl-CoA dehydrogenases 
(EC 1.3.99.3) has been developed [9]. These enzymes 
may represent the rate-limiting stage of/3-oxidation 
[10], and it is therefore of some interest to examine 
effects of pent-4-enoylcarnitine with this assay. 
2. Materials and methods 
Liver mitochondria from male albino Wistar rats 
(150-200 g) were prepared as in [9]. Acylcamitines 
were prepared as in [ l l ] .  The purity of the prepara- 
tions were checked with thin-layer chromatography 
[1 l] and by gas chromatography, the free acid 
content was less than 1%. 
The acylcarnitine-dependent reduction of ferri- 
Elsevier/North-Holland Biomedical Press 219 
Volume 88, number 2 FEBS LETTERS April 1978 
cyanide was measured by using an Aminco DW-2 
spectrophotometer, operated in dual wavelength 
mode at 420 nm and 475 nm. The details of the assay 
are in [9]. With this assay the rate of reduction of 
ferricyanide is a direct measure of the acyl-CoA flux 
through the acyl-CoA dehydrogenases. Maximal rates 
of/~-oxidation by rotenone-blocked mitochondria 
were achieved by the addition of 10 mM oxaloacetate, 
the latter being acceptor for both reducing equivalents 
as well as acetyl-groups ( ee [9]). 
Purified hypoglycin was a gift from Dr H. S. A. 
Sherratt, Dept. Pharmacol. Sci. University of Newcastle 
upon Tyne, and had been prepared as in [5]. 
Mitochondrial protein concentrations were as- 
sayed by using the biuret assay [ 12], with Precimat 
(Boehringer GMBH, Mannheim) protein standards. 
3. Results and discussion 
When the mitochondrial oxidation of saturated or 
unsaturated acylcarnitines i measured by using the 
spectrophotometric assay [9] traces qualitatively 
identical to that shown in fig.1 with myristoylcarnitine 
are obtained, viz., the addition of acylcarnitine give 
some stimulation of the rate of reduction of ferri- 
cyanide. This represents the rotenone-insensitive 
component of ~-oxidation [9,13]. This rate is stimu- 
lated several-fold on the addition of 10 mM oxalo- 
acetate (see fig.1 (c)). The addition of pent-4-enoyl- 
carnitine similarly give a rotenone-insensitive rate of 
/~-oxidation. On the addition of oxaloacetate, however, 
this rate is instantaneously blocked, as is also the 
oxidation of subsequently added myristoylcarnitine. 
On adding oxaloacetate prior to the addition of 
pent-4-enoylcarnitine there is no apparent oxidation 
of this acylcarnitine. Surprisingly, the oxidation of 
subsequently added myristoylcarnitine is also now 
completely blocked (see fig.l). 
The results presented in fig.2 show that the 
rotenone-insensitive rate of oxidation of pent-4- 
enoylcarnitine decreases towards zero with time 
(in the absence of added oxal0acetate). This is analo- 
gous to the self-limiting pulse of respiration with 
pent-4-enoylcarnitine [2]. The oxidation ofmyristoyl- 
carnitine added towards the end of the pulse of pent- 
4-enoylcamitine oxidation is also 100% inhibited, 
also in agreement with earlier polarographic results 
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Fig.1. The effect of oxaloacetate onthe pent-4-enoyl- 
carnitine dependent flux through acyl-CoA dehydrogenases. 
The reduction of ferricyanide was recorded as described in 
section 2. Typical traces obtained when 10 mM oxaloacetate 
is added after pent-4-enoylcarnitine (a)and before pent-4- 
enoylcarnitine (b). A trace obtained with myristoylcarnitines, 
which is qualitatively identical to traces obtained with all 
other saturated acylcarnitines tested is also shown (e). In this 
case the order of addition of oxaioacetate is of no significance 
to the final rate (not shown). The numbers in parentheses 
represent rates of ferricyanide reduction expressed as nmol/ 
min/mg protein. 
Abbreviations: OxAc, oxaloacetate; P4-carn, pent-4-enoyl- 
carnitine; Myr.carn, myristoylcarnitine. Each assay contained 
1.6 mg mitochondrial protein. 
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Fig.2. The self-limiting nature of rotenone-insensitive pent-4- 
enoylcarnitine oxidation. A typical trace, obtained as in 
section 2, showing that pent-4-enoylcamitine dependent acyl- 
CoA dehydrogenase flux decreases with time (a). A trace 
showing the effect of addition of pent-4-enoylcarnitine 
during sustained oxidation of myristoylcarnitine is also 
shown (b). Each assay contained 2.3 mg mitochondrial 
protein. The assay details are otherwise as in fig.1 legend. 
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[2]. Results presented in fig.2 also show that when 
pent-4-enoyl-carnitine is added during sustained 
oxidation of myristoylcarnitine, progressive inhibi- 
tion of the acyl-CoA flux results. 
The hypoglycin metabolite methylenecyclo- 
propylacetyl-CoA selectively inhibits butyryl-CoA 
dehydrogenase (EC 1.3.99.2), while palmitoyl-CoA 
dehydrogenase i  not inhibited [14,15]. It was 
therefore of interest to study the effect of blocked 
butyryl-CoA dehydrogenase on pent-4-enoylcarnitine- 
dependent acyl-CoA fluxes. Rats which had been 
deprived of food for 12 h were given 80 mg hypo- 
glycin/kg body wt. Control rats were given a similar 
volume of saline. After further 12 h livers were 
removed, and mitochondria prepared. Some aspects 
of the effect of hypoglycin administration  acyl- 
CoA dehydrogenase flux are in [9]. As expected the 
oxidation of butyrylcarnitine is completely blocked, 
while there is some residual oxidation of subsequently 
added hexanoylcarnitine (s e fig.3). Interestingly, 
hexanoylcamitine oxidation by mitchondria from 
hypoglycin-treated rats shows a property characteristic 
of butyrylcamitine oxidation by control mitochondria, 
in that its oxidation is not further stimulated by 
added oxaloacetate (fig.3). Myristoylcarnitine gives 
traces which are qualitatively identical to those of 
control mitochondria, lthough the post-oxaloacetate 
rate of oxidation is only about 50% of the control 
rate. This agrees with [9,14]. Results presented in
fig.3 also show that the rotenone-insensitive oxidation 
of pent-4-enoylcamitine is completely abolished in 
mitochondria from hypoglycin treated rat, the 
addition of oxaloacetate b ing without any detectable 
effect. 
This investigation shows that pent-4-enoylcarnitine 
is treated by the/3-oxidation system in a manner not 
shown by any other unsaturated acylcarnitines which 
has been investigated (H. O. unpublished). The 
inhibitory effect of oxaloacetate strongly suggests 
that some metabolite of pent-4-enoyl-CoA is power- 
fully inhibitory to/3-oxidation. It is likely that an 
inhibitory concentration f this metabolite is formed 
practically instantaneously when the NADH-block of 
/3-oxidation (imposed by rotenone) isbypassed on the 
addition of oxaloacetate. 
A very small amount of this metabolite, perhaps 
3-oxo-pent4-enoyl-CoA, is deafly adequate to cause 
nearly 100% block of the oxidation of subsequently 
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Fig.3. The effect of hypoglycine-induced block of butyryl- 
CoA dehydrogenase on acylcarnitine d pendent fluxes 
through the acyl-CoA dehydrogenases. Typical traces 
obtained from butyrylearnitine (a)and hexanoylcarnitine (b) 
with control mitochondria (1.1 mg protein/assay), and with 
mitochondria from a hypoglycine-treated rat (c) (1.4 mg 
mitochondrial protein/assay). The effect of hypoglycine 
treatment ofoxidation of pent-4-enoylcarnitine s also shown 
(d). 
Abbreviations." B ut.carn, butyrylcarnitine; Hex.carn, hexanoyl- 
carnitine. 
The details of the assay are otherwise as in fig.1 legend. 
added myristoylcamitine. This is indicated by the 
inhibited myristoylcamitine oxidation also observed 
when oxaloacetate had been added to the mitochon- 
dria prior to the addition of pent-4-enoylcarnitine 
(see fig.l). In this case there was no detectable 
oxidation of pent-4-enoylcamitine. Thecause of this 
inhibition cannot simply be due to CoA sequestration 
as unmetabolised pent-4-enoyl-CoA (pent-4-enoyl- 
carnitine is an excellent substrate for carnitine 
acetyl-transferase (EC 2.3.1.7) [18] ), as is shown by 
the oxidation of pent-4-enoylcarnitine which takes 
place in the absence of added oxaloacetate (fig.2). 
The amount of ferricyanide r duced uring this self- 
limiting pulse of oxidation corresponds tothe passage 
of about 15 nmoles pent-4-enoyl-CoA through the 
acyl-CoA dehydrogenase. This corresponds to at least 
3 times available intra-mitochondrial CoA, assuming a
value of about 2 nmol CoA/mg mitochondrial protein 
[2,16 ]. Therefore~ recycling of CoA must have taken 
place before/3-oxidation ceases. Similar esults were 
reported on the basis of polarographic work [2]. It is 
therefore likely that the rotenone-insensitive oxidation 
of pent-4-enoylcamitine is s lf-limiting because the 
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build up of an inhibitory concentration of the required 
metabolite is very slow under these conditions. This 
also suggests that the inhibitory metabolite is gener- 
ated by a reaction distally in the f3-oxidation sequence 
to the NADH-block, i.e., by the j3-hydroxyacyl-CoA 
dehydrogenase (EC 1.1.1.35) or by the acetoacetyl- 
CoA thiolase. The enoyl-CoA hydratase (EC 4.2.1.17) 
does not appear to be inhibited in rotenone-blocked 
mitochondria s 13-hydroxyacyl-esters have been 
found to accumulate under these conditions [13]. 
The absence of rotenone-insensitive oxidation of 
pent-4-enoylcarnitine  mitochondria blocked with 
butyryl-CoA dehydrogenases show that the oxidation 
of this acyl-CoA species is solely due to the activity 
of butyryl-CoA dehydrogenase. It is therefore note- 
worthy that an acyl-CoA species which is metabolised 
by butyryl-CoA dehydrogenase i  able to inhibit the 
oxidation of fatty acids of all chain lengths [2]. 
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